Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of A2 Dairy Consumption in Celiac Adolescents
Sponsor: Halic University
Summary
The goal of this clinical trial is to evaluate the effect of A2 β-casein-containing milk and dairy product consumption on nutritional status, gastrointestinal symptoms, quality of life, sleep quality, and selected biochemical parameters in adolescents aged 10-18 years with celiac disease. The main questions it aims to answer are: * Does consumption of A2 β-casein-containing milk and dairy products improve gastrointestinal symptoms and quality of life in adolescents with celiac disease? * Does consumption of A2 β-casein-containing milk and dairy products affect nutritional status, body composition, and biochemical parameters compared with standard milk and dairy products? Researchers will compare adolescents consuming A2 β-casein-containing milk and dairy products with adolescents consuming standard milk and dairy products to see if A2 β-casein provides additional benefits. Participants will: * Consume the assigned milk and dairy products during the intervention period. * Attend baseline and follow-up assessments. * Complete dietary records and questionnaires related to gastrointestinal symptoms, sleep quality, and quality of life. * Undergo anthropometric, body composition, hand grip strength, and biochemical assessments.
Official title: Evaluation of the Effects of Consumption of Milk and Dairy Products Containing A2 β-Casein on Nutritional Status, Quality of Life, and Certain Blood Parameters in Adolescents With Celiac Disease
Key Details
Gender
All
Age Range
10 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2022-02-01
Completion Date
2026-07-03
Last Updated
2026-09-11
Healthy Volunteers
Yes
Interventions
A2 β-casein milk and dairy products
Participants consumed milk and dairy products containing A2 β-casein during the 8-week intervention period.
Standard milk and dairy products
Participants consumed standard milk and dairy products during the 8-week intervention period.
Locations (1)
Sariyer Hamidiye Etfal Training and Research Hospital
Istanbul, Turkey (Türkiye)